Thermo Fisher and SHL Medical Partner for Integrated Drug-Device Solutions in the U.S.

Thermo Fisher Scientific has announced a strategic collaboration with SHL Medical to provide integrated drug-device solutions. The partnership focuses on expanding sterile fill-finish and autoinjector final assembly capabilities at the Ridgefield, New Jersey facility. This project aims to establish a fully integrated U.S.-based offering that spans manufacturing, assembly, and commercial packaging. By localizing the end-to-end solution, the companies intend to streamline the production and supply chain for drug-device combination products. This expansion strengthens Thermo Fisher’s market position in the high-growth drug delivery sector, potentially boosting long-term revenue from pharmaceutical clients. The collaboration reflects a strategic move to meet the increasing demand for advanced pharmaceutical manufacturing within the United States.

Sources:businesswire.commorningstar.comiocbc.cominitse.comstar-k.orgadvanced.onlinelibrary.wiley.commarketscreener.comzonebourse.com